Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 120 Total
LILAK - Liberty Latin America Ltd - Stock Price Chart
TickerLILAK [NASD, RUT]
CompanyLiberty Latin America Ltd
CountryUSA
IndustryTelecom Services
Market Cap928.05MEPS (ttm)-4.03
P/E-EPS this Y97.97%
Forward P/E8.14EPS next Y956.65%
PEG-EPS past 5Y-51.17%
P/S0.21EPS next 5Y-
P/B0.92EPS Q/Q-27524.00%
Dividend-Sales Q/Q-1.45%
Insider Own35.96%Inst Own50.95%
Insider Trans0.37%Inst Trans-
Short Float2.73%EarningsMay 07/a
Analyst Recom2.25Target Price8.84
Avg Volume1.04M52W Range5.09 - 10.93
Liberty Latin America Ltd. is a holding company, which engages in the provision of fixed, mobile, and subsea telecommunications services. It operates through the following segments: C and W Carribean, C and W Panama, Liberty Networks, Liberty Puerto Rico, Liberty Costa Rica, and VTR. The company was founded in 1999 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jacobson Roberta S.DirectorMar 26 '25Sale6.499,60062,31127,404Mar 28 04:06 PM
ROBERTA JACOBSONDirectorMar 26 '25Proposed Sale6.499,60062,311Mar 26 04:19 PM
Zinterhofer Eric LouisDirectorMar 15 '25Option Exercise0.0023,6220115,352Mar 18 05:27 PM
Sanchez Daniel E.DirectorMar 15 '25Option Exercise0.0023,622044,759Mar 18 05:25 PM
PADDICK BRENDAN JDirectorMar 15 '25Option Exercise0.0023,62201,958,499Mar 18 05:22 PM
LILA - Liberty Latin America Ltd - Stock Price Chart
TickerLILA [NASD, RUT]
CompanyLiberty Latin America Ltd
CountryUSA
IndustryTelecom Services
Market Cap928.05MEPS (ttm)-4.03
P/E-EPS this Y97.32%
Forward P/E8.02EPS next Y758.87%
PEG-EPS past 5Y-51.17%
P/S0.21EPS next 5Y-
P/B0.91EPS Q/Q-27524.00%
Dividend-Sales Q/Q-1.45%
Insider Own83.46%Inst Own15.18%
Insider Trans0.16%Inst Trans0.45%
Short Float2.08%EarningsMay 07/a
Analyst Recom2.43Target Price8.74
Avg Volume475.18K52W Range5.12 - 10.81
Liberty Latin America Ltd. is a holding company, which engages in the provision of fixed, mobile, and subsea telecommunications services. It operates through the following segments: C and W Carribean, C and W Panama, Liberty Networks, Liberty Puerto Rico, Liberty Costa Rica, and VTR. The company was founded in 1999 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jacobson Roberta S.DirectorMar 26 '25Sale6.499,60062,31127,404Mar 28 04:06 PM
ROBERTA JACOBSONDirectorMar 26 '25Proposed Sale6.499,60062,311Mar 26 04:19 PM
Zinterhofer Eric LouisDirectorMar 15 '25Option Exercise0.0023,6220115,352Mar 18 05:27 PM
Sanchez Daniel E.DirectorMar 15 '25Option Exercise0.0023,622044,759Mar 18 05:25 PM
PADDICK BRENDAN JDirectorMar 15 '25Option Exercise0.0023,62201,958,499Mar 18 05:22 PM
TOVX - Theriva Biologics Inc - Stock Price Chart
TickerTOVX [AMEX]
CompanyTheriva Biologics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.79MEPS (ttm)-26.66
P/E-EPS this Y70.99%
Forward P/E-EPS next Y-4.71%
PEG-EPS past 5Y39.99%
P/S-EPS next 5Y36.86%
P/B0.09EPS Q/Q80.01%
Dividend-Sales Q/Q-
Insider Own1.04%Inst Own1.24%
Insider Trans0.00%Inst Trans-82.73%
Short Float3.51%EarningsMar 06/a
Analyst Recom1.00Target Price6.00
Avg Volume802.90K52W Range0.74 - 12.28
Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-020 and SYN-004. SYN-020 is intended to prevent the antibiotic-mediated microbiome damage, C. difficile infections (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR) and acute graft-versus-host disease (aGVHD) in allogeneic HCT recipients. SYN-004 is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antimicrobial resistance. The company was founded by Steven H. Kanzer on January 8, 2001 and is headquartered in Rockville, MD.
ADTX - Aditxt Inc - Stock Price Chart
TickerADTX [NASD]
CompanyAditxt Inc
CountryUSA
IndustryBiotechnology
Market Cap192.71MEPS (ttm)-161133.90
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y83.15%
P/S1482.38EPS next 5Y-
P/B0.44EPS Q/Q99.95%
Dividend-Sales Q/Q-96.09%
Insider Own0.00%Inst Own0.01%
Insider Trans-Inst Trans0.01%
Short Float0.21%Earnings-
Analyst Recom1.00Target Price610000.00
Avg Volume3.09M52W Range1.81 - 27200.00
May-02-25 09:00AM Upcoming Aditxt Weekly Update to Feature Dr. Shahrokh Shabahang, Chief Innovation Officer (CIO) of Aditxt, and Dr. Friedrich Kapp, Co-CEO of Adimune, to Discuss Progress of Lead Therapeutic Candidate ADI-100 (Business Wire)
Apr-17-25 09:08PM KILL Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome Human Trials (Business Wire) +13.64% -10.80%
09:03PM KILL Dr. Charles Howe of the Mayo Clinics Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxts Subsidiary Adimune (Business Wire)
08:15AM Dr. Charles Howe of the Mayo Clinics Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxts Subsidiary Adimune (Business Wire)
Apr-16-25 08:15AM Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 (Business Wire) -8.71%
Apr-14-25 08:15AM Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome Human Trials (Business Wire) -13.19%
Apr-11-25 08:15AM Aditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing Requirements (Business Wire)
Apr-10-25 09:24AM Why Aditxt Inc. (ADTX) Went Down On Thursday? (Insider Monkey)
Apr-09-25 08:15AM Aditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing Requirements (Business Wire) -8.81%
Apr-02-25 08:17AM Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025 (GlobeNewswire) +10.62%
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HRT FINANCIAL LP10% OwnerOct 15 '24Buy1.5015,63623,45425,434Oct 17 01:58 PM
HRT FINANCIAL LP10% OwnerOct 16 '24Sale1.1725,53429,8750Oct 17 01:58 PM
BDSX - Biodesix Inc - Stock Price Chart
TickerBDSX [NASD]
CompanyBiodesix Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap50.93MEPS (ttm)-0.35
P/E-EPS this Y37.53%
Forward P/E-EPS next Y33.89%
PEG-EPS past 5Y69.26%
P/S0.71EPS next 5Y37.65%
P/B2.42EPS Q/Q43.13%
Dividend-Sales Q/Q39.28%
Insider Own49.38%Inst Own38.37%
Insider Trans0.25%Inst Trans-12.01%
Short Float1.38%EarningsMay 13/a
Analyst Recom1.00Target Price2.90
Avg Volume457.85K52W Range0.41 - 2.04
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vazquez ChrisChief Accounting OfficerFeb 11 '25Sale0.923,6303,35517,623Feb 12 05:12 PM
Pestano Gary AnthonyChief Development OfficerFeb 11 '25Sale0.9216,74815,479156,008Feb 12 05:12 PM
O'Kane KieranChief Commercial OfficerFeb 11 '25Sale0.9217,52716,198128,039Feb 12 05:11 PM
Hutton ScottPresident & CEOFeb 11 '25Sale0.9283,66077,319701,947Feb 12 05:11 PM
Cowie Robin HarperCFO, Sec'y & TreasurerFeb 11 '25Sale0.9224,66422,794246,460Feb 12 05:11 PM
PTPI - Petros Pharmaceuticals Inc - Stock Price Chart
TickerPTPI [NASD]
CompanyPetros Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap0.27MEPS (ttm)-90.40
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y55.46%
P/S0.05EPS next 5Y-
P/B-EPS Q/Q55.57%
Dividend-Sales Q/Q-56.68%
Insider Own18.16%Inst Own1.82%
Insider Trans0.00%Inst Trans-
Short Float6.86%Earnings-
Analyst Recom1.00Target Price25.00
Avg Volume3.47M52W Range0.14 - 18.00
Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharma co-vigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, an FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie's disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.
ASPN - Aspen Aerogels Inc - Stock Price Chart
TickerASPN [NYSE, RUT]
CompanyAspen Aerogels Inc
CountryUSA
IndustryBuilding Products & Equipment
Market Cap353.87MEPS (ttm)0.16
P/E27.72EPS this Y-811.86%
Forward P/E11.43EPS next Y131.16%
PEG0.37EPS past 5Y-
P/S0.81EPS next 5Y75.36%
P/B0.58EPS Q/Q-15068.60%
Dividend-Sales Q/Q-16.70%
Insider Own1.78%Inst Own89.97%
Insider Trans0.00%Inst Trans4.44%
Short Float11.33%EarningsMay 08/b
Analyst Recom1.56Target Price13.50
Avg Volume2.13M52W Range4.80 - 33.15
May-08-25Downgrade Oppenheimer Outperform → Perform
Aspen Aerogels, Inc. engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. It operates through the Energy Industrial and Thermal Barrier segments. The Energy Industrial segment designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in the energy industrial and sustainable insulation markets. The Thermal Barrier segment is actively developing aerogel products and technologies for the EV market. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee in May 2001 and is headquartered in Northborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Young Donald RPresident and CEOSep 30 '24Sale30.0363,3551,902,551483,640Oct 01 11:31 AM
Donald R. YoungPresident, CEO, DirectorSep 30 '24Proposed Sale27.62134,6293,718,452Sep 30 04:42 PM
RODRIGUEZ RICARDO C.CFO & TreasurerAug 26 '24Option Exercise6.8125,300172,29353,255Aug 28 02:59 PM
RODRIGUEZ RICARDO C.CFO & TreasurerAug 26 '24Sale30.1432,465978,38720,790Aug 28 02:59 PM
RICARDO RODRIGUEZOfficerAug 26 '24Proposed Sale30.1432,465978,495Aug 26 04:26 PM
WAI - Top KingWin Ltd - Stock Price Chart
TickerWAI [NASD]
CompanyTop KingWin Ltd
CountryChina
IndustryCapital Markets
Market Cap24.68MEPS (ttm)-0.03
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S47.46EPS next 5Y-
P/B83.80EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own42.95%Inst Own0.11%
Insider Trans0.00%Inst Trans248.16%
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume10.83K52W Range2.30 - 20.00
May-01-25 08:00AM Top KingWin Ltd Announces 1-For-25 Reverse Share Split (GlobeNewswire) -16.40%
Apr-03-25 07:30AM Top Kingwin Ltd's Subsidiary Tiancheng Chuangxin Technology Announces its Plan to Launch Desktop Robot 1.0 - Redefining the Smart Office Companion (GlobeNewswire) -17.60%
Feb-19-25 08:00AM Top KingWin Ltd Announces $1,000,000 Convertible Promissory Note Offering and Up to $28,500,000 Additional Note Offering (GlobeNewswire)
Nov-26-24 04:05PM Top KingWin Limited Announces $2,500,000 Convertible Promissory Note Private Placement (GlobeNewswire) -19.19% +87.08%
Nov-07-24 09:28AM Top Kingwin Ltd's Subsidiary, Guji Technology, Achieves RMB 2Million in Revenue for October 2024 (GlobeNewswire) +5.31%
Oct-17-24 09:00AM Top KingWin Ltd. Announces Trading Ticker Symbol Change to WAI (GlobeNewswire)
Sep-23-24 09:42AM Top KingWin Announces Update to Supply Chain Business - Tuoxun Technology (Shenzhen) Co., Ltd. Signs A Letter of Intent with Top KingWin's Subsidiary, Guji Technology (Shenzhen) Co., Ltd. (GlobeNewswire) +10.25%
Sep-13-24 09:00AM Top KingWin's wholly owned subsidiary, Guji Technology (Shenzhen) Co., Ltd., Orders Servers to Provide Hardware Support for AI Business Development (GlobeNewswire)
Aug-29-24 09:00AM Shenzhen Tomorrow Innovation Core Technology Co., Ltd. Acquired Guji Technology, Strengthening AI Strategic Layout (GlobeNewswire)
Aug-26-24 09:00AM TCJH Establishes Shenzhen Tomorrow Innovation Core Technology Co., LTD to Lead in AI Hardware Supply Chain and Intelligent System Integration (GlobeNewswire) +14.67%
Top KingWin Ltd. is a holding company that engages in the provision of corporate business training, corporate consulting, and advisory and transaction services. It provides customized software development, technology solutions, and peripheral hardware to clients, and focusing on fields such as intelligent manufacturing, urban construction, and healthcare industry. The company was founded by Rui Lin Xu in 2020 and is headquartered in Guangzhou, China.
ABP - Abpro Holdings Inc - Stock Price Chart
TickerABP [NASD]
CompanyAbpro Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap10.04MEPS (ttm)-0.21
P/E-EPS this Y-77.78%
Forward P/E-EPS next Y-25.00%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-902.44%
Dividend-Sales Q/Q-
Insider Own46.52%Inst Own2.90%
Insider Trans0.16%Inst Trans139.03%
Short Float0.20%EarningsFeb 26
Analyst Recom1.00Target Price2.00
Avg Volume286.62K52W Range0.21 - 13.00
Apr-27-25 02:00PM Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager (GlobeNewswire)
Mar-25-25 04:30PM Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 (GlobeNewswire) -9.45%
Mar-10-25 06:34PM Abpro Statement on the Departure of Former CEO Ian Chan (GlobeNewswire) -5.10%
Dec-12-24 04:05PM Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing (GlobeNewswire)
Jun-13-24 04:15PM Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q (PR Newswire)
Jan-22-24 08:00AM Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II (GlobeNewswire)
Oct-18-23 04:15PM Atlantic Coastal Acquisition Corp. II Announces Extension of Business Combination Period and Additional Contribution to Trust Account (PR Newswire)
Sep-06-23 08:11AM IMPORTANT: Atlantic Coastal Acquisition Corp. Files Definitive Proxy Statement in Connection with Plan to Extend the Amount of Time the Company has to Consummate a Business Combination (PR Newswire)
Aug-25-23 04:11PM Atlantic Coastal Acquisition Corp. Announces Plans to Extend Deadline to Complete Initial Business Combination. (PR Newswire)
Aug-18-23 04:11PM Atlantic Coastal Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination (PR Newswire)
Abpro Holdings, Inc. operates as a capital pool company. The company was founded in 2004 and is headquartered in Woburn, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Suk Jin Wook (Miles)CEO and ChairmanApr 29 '25Buy0.254,3251,081130,277May 01 04:21 PM
Suk Jin Wook (Miles)CEO and ChairmanApr 24 '25Buy0.3426,5429,024125,902Apr 25 04:58 PM
Suk Jin Wook (Miles)CEO and ChairmanApr 23 '25Buy0.287,4602,08999,360Apr 25 04:58 PM
ERII - Energy Recovery Inc - Stock Price Chart
TickerERII [NASD, RUT]
CompanyEnergy Recovery Inc
CountryUSA
IndustryPollution & Treatment Controls
Market Cap667.62MEPS (ttm)0.36
P/E33.62EPS this Y35.46%
Forward P/E17.20EPS next Y31.45%
PEG1.11EPS past 5Y15.42%
P/S4.74EPS next 5Y30.29%
P/B3.39EPS Q/Q-24.48%
Dividend-Sales Q/Q-33.29%
Insider Own3.55%Inst Own84.72%
Insider Trans-5.85%Inst Trans-7.81%
Short Float2.09%EarningsMay 07/a
Analyst Recom2.33Target Price17.17
Avg Volume448.54K52W Range12.26 - 20.27
May-08-25Downgrade B. Riley Securities Buy → Neutral $12.50
Energy Recovery, Inc. engages in the design and manufacture of industrial fluid flow solutions. It operates through the following segments: Water, Emerging Technologies, and Corporate. The Water segment deals with the development, sales, and support of the PX, Turbochargers and pumps used in seawater desalination and industrial wastewater activities. The Emerging Technologies segment is composed of the development of the PX G1300 used in industrial and commercial refrigeration applications. The company was founded in April 1992 and is headquartered in San Leandro, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FARSHAD GHASRIPOORFormer OfficerApr 24 '25Proposed Sale14.9012,624188,110Apr 25 04:24 PM
Ghasripoor FarshadFormer OfficerMar 17 '25Proposed Sale16.2047,989777,226Mar 17 01:48 PM
Hanstveit ArveDirectorMar 11 '25Sale16.3450,000816,950693,182Mar 13 04:24 PM
Clemente RodneySVP, WaterMar 11 '25Sale16.231,84329,912108,472Mar 12 04:57 PM
Hanstveit ArveDirectorMar 11 '25Proposed Sale16.3250,000816,243Mar 11 03:33 PM
12345671012